392 related articles for article (PubMed ID: 11156402)
81. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
[TBL] [Abstract][Full Text] [Related]
82. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
Grauer OM; Sutmuller RP; van Maren W; Jacobs JF; Bennink E; Toonen LW; Nierkens S; Adema GJ
Int J Cancer; 2008 Apr; 122(8):1794-802. PubMed ID: 18076066
[TBL] [Abstract][Full Text] [Related]
83. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.
Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
Cancer Res; 1998 Feb; 58(3):380-3. PubMed ID: 9458075
[TBL] [Abstract][Full Text] [Related]
84. Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes.
van Hall T; van de Rhee NE; Schoenberger SP; Vierboom MP; Verreck FA; Melief CJ; Offringa R
Cancer Res; 1998 Jul; 58(14):3087-93. PubMed ID: 9679975
[TBL] [Abstract][Full Text] [Related]
85. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
Schnell S; Young JW; Houghton AN; Sadelain M
J Immunol; 2000 Feb; 164(3):1243-50. PubMed ID: 10640737
[TBL] [Abstract][Full Text] [Related]
86. Antitumor immune response of dendritic cells (DCs) expressing tumor-associated antigens derived from induced pluripotent stem cells: in comparison to bone marrow-derived DCs.
Iwamoto H; Ojima T; Hayata K; Katsuda M; Miyazawa M; Iida T; Nakamura M; Nakamori M; Iwahashi M; Yamaue H
Int J Cancer; 2014 Jan; 134(2):332-41. PubMed ID: 23824921
[TBL] [Abstract][Full Text] [Related]
87. Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity.
Shinozaki Y; Wang S; Miyazaki Y; Miyazaki K; Yamada H; Yoshikai Y; Hara H; Yoshida H
Int J Cancer; 2009 Mar; 124(6):1372-8. PubMed ID: 19089917
[TBL] [Abstract][Full Text] [Related]
88. Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma-associated antigens.
Bystryn JC
J Immunol; 1978 Jan; 120(1):96-101. PubMed ID: 627729
[TBL] [Abstract][Full Text] [Related]
89. Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax.
Mansour M; Pohajdak B; Kast WM; Fuentes-Ortega A; Korets-Smith E; Weir GM; Brown RG; Daftarian P
J Transl Med; 2007 Apr; 5():20. PubMed ID: 17451606
[TBL] [Abstract][Full Text] [Related]
90. A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination.
Gálvez-Cancino F; Roco J; Rojas-Colonelli N; Flores C; Murgas P; Cruz-Gómez S; Oyarce C; Varas-Godoy M; Sauma D; Lladser A
Vaccine; 2017 Jul; 35(33):4148-4154. PubMed ID: 28666759
[TBL] [Abstract][Full Text] [Related]
91. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
[TBL] [Abstract][Full Text] [Related]
92. MHC class I genes controlling the metastatic phenotype of tumor cells.
Feldman M; Eisenbach L
Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
[TBL] [Abstract][Full Text] [Related]
93. Resistance to tumor growth mediated by Listeria monocytogenes. Destruction of experimental malignant melanoma by LM-activated peritoneal and lymphoid cells.
Youdim S
J Immunol; 1976 Mar; 116(3):579-84. PubMed ID: 56396
[TBL] [Abstract][Full Text] [Related]
94. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.
Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X
J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903
[TBL] [Abstract][Full Text] [Related]
95. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.
DeMatos P; Abdel-Wahab Z; Vervaert C; Hester D; Seigler H
J Surg Oncol; 1998 Jun; 68(2):79-91. PubMed ID: 9624036
[TBL] [Abstract][Full Text] [Related]
96. Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue.
Mac Keon S; Gazzaniga S; Mallerman J; Bravo AI; Mordoh J; Wainstok R
Vaccine; 2010 Nov; 28(51):8162-8. PubMed ID: 20937314
[TBL] [Abstract][Full Text] [Related]
97. Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas.
Mandelboim O; Bar-Haim E; Vadai E; Fridkin M; Eisenbach L
J Immunol; 1997 Dec; 159(12):6030-6. PubMed ID: 9550401
[TBL] [Abstract][Full Text] [Related]
98. Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.
Mac Keon S; Bentivegna S; Levy EM; Marks MS; Mantegazza AR; Wainstok R; Mordoh J
Vaccine; 2019 Aug; 37(35):4947-4955. PubMed ID: 31307876
[TBL] [Abstract][Full Text] [Related]
99. Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination.
Kast WM; Brandt RM; Melief CJ
Eur J Immunol; 1993 May; 23(5):1189-92. PubMed ID: 8386667
[TBL] [Abstract][Full Text] [Related]
100. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.
Koppenhagen FJ; Küpcü Z; Wallner G; Crommelin DJ; Wagner E; Storm G; Kircheis R
Clin Cancer Res; 1998 Aug; 4(8):1881-6. PubMed ID: 9717815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
